Fatigue and cognitive impairment after COVID-19: A prospective multicentre study

TJ Hartung, C Neumann, T Bahmer… - …, 2022 - thelancet.com
Background Reliable estimates of frequency, severity and associated factors of both fatigue
and cognitive impairment after COVID-19 are needed. Also, it is not clear whether the two …

Clinical outcome assessments in encephalitis: a systematic review

J Brenner, SHC Olijslagers, YS Crijnen… - Neurology …, 2023 - AAN Enterprises
Background and Objectives Most patients with encephalitis experience persisting
neurocognitive and neuropsychiatric sequelae in the years following this acute illness …

[HTML][HTML] Outcome and Sequelae of Autoimmune Encephalitis

KA Kvam, JP Stahl, FC Chow, A Soldatos… - Journal of Clinical …, 2024 - ncbi.nlm.nih.gov
Autoimmune etiologies are a common cause for encephalitis. The clinical syndromes
consistent with autoimmune encephalitis are both distinct and increasingly recognized, but …

Development and validation of a risk score to differentiate viral and autoimmune encephalitis in adults

A Granillo, M Le Maréchal, L Diaz-Arias… - Clinical Infectious …, 2023 - academic.oup.com
Background Encephalitis represents a challenging condition to diagnose and treat. To assist
physicians in considering autoimmune encephalitis (AE) sooner, we developed and …

Younger age at onset is associated with worse long-term behavioral outcomes in anti-NMDA receptor encephalitis

A Yeshokumar, E Gordon-Lipkin… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Anti-NMDA receptor encephalitis (anti-NMDARE) is one of the
most common causes of encephalitis. It typically presents in adolescence and young …

Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis

SNM Binks, M Veldsman, AE Handel… - Annals of Clinical …, 2024 - Wiley Online Library
Patient‐reported quality‐of‐life (QoL) and carer impacts are not reported after leucine‐rich
glioma‐inactivated 1‐antibody encephalitis (LGI1‐Ab‐E). From 60 patients, 85%(51 out of …

Assessment of long-term psychosocial outcomes in N-methyl-D-aspartate receptor encephalitis–the SAPIENCE study protocol

OJ Boeken, J Heine, M Duda-Sikula, V Patricio… - BMC neurology, 2024 - Springer
Background N-methyl-D-aspartate-receptor (NMDAR) encephalitis is a rare neurological
autoimmune disease with severe neuropsychiatric symptoms during the acute phase …

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG …

ST Lee, H Abboud, SR Irani, H Nakajima… - Frontiers in …, 2024 - frontiersin.org
Background Autoimmune encephalitis (AIE) encompasses a spectrum of rare autoimmune-
mediated neurological disorders, which are characterized by brain inflammation and …

Long-term outcomes and health-related quality of life in patients with autoimmune encephalitis: An observational study

Y Yokota, S Hirose, M Hara, H Nakajima - Medicine, 2023 - journals.lww.com
Autoimmune encephalitis (AE) subacutely causes severe and multiple symptoms; however,
most patients achieve neurologically favorable outcomes. Despite the substantial recovery …

Patient-Reported Outcome Measures in NMDA Receptor Encephalitis

J Heine, OJ Boeken, S Rekers, K Wurdack… - Neurology …, 2024 - neurology.org
Background and Objectives The characteristics of persistent long-term symptoms and their
contribution to subjective quality of life remain unclear in patients with NMDAR encephalitis …